News PT Kalbe Farma Tbk.

Equities

KLBF

ID1000125107

End-of-day quote INDONESIA S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
1,430 ^IDR	+1.78%		-1.72%	-11.18%

Apr. 01	PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 20	Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy	Feb. 20	MT
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)	23-10-23	BU
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius novel anti-PD-1 mAb HANSIZHUANG in MENA	23-09-13	AQ
PT Kalbe Farma Tbk : KIMIA FARMA & KALBE FARMA COLLABORATED TO IMPROVE HEALTH SERVICES FOR THE SOCIETY	23-08-31	PU
PT Kalbe Farma Tbk. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-06	CI
PT Kalbe Farma Tbk : KALBE INTRODUCES MESOTHERAPY PRODUCTS IN AESTHETIC TREATMENT	23-07-16	PU
PT Kalbe Farma Tbk : KALBE INTRODUCES AUTOIMMUNE DISEASES FURTHER	23-07-07	PU
Ex-dividend day for final dividend	23-05-11	FA
PT Kalbe Farma Tbk : Kalbe Announced Dividend of 52% from Net Profit	23-05-04	PU
PT Kalbe Farma Tbk : 2022, Recover Together for Healthier Nation	23-05-02	PU
PT Kalbe Farma Tbk : Kalbe Maintained Double Digit Top Line Growth in the First Quarter of 2023	23-04-28	PU
PT Kalbe Farma Tbk : Company Update - Q1 2023 Unaudited Results (28-April-2023)	23-04-28	PU
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
PT Kalbe Farma Tbk : THE INAUGURATION OF THE KALBE UBAYA HANBANG-BIO LABORATORY PILOT PLANT, SUPPORTING THE INDEPENDENCE OF NATIONAL INGREDIENTS	23-03-01	PU
Nomura Adjusts Kalbe Farma’s Price Target to IDR2,500 From IDR2,250, Keeps at Buy	23-01-30	MT
Progen Co. Ltd. announced that it has received IDR 155.72 billion in funding from PT Kalbe Farma Tbk.	23-01-01	CI
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PT Kalbe Farma Tbk.

Equities

KLBF

ID1000125107

Summary

Filters